Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation.

Similarities in microbiota assemblages between the 2 cohorts support a broader scope for microbiota-directed therapeutics than previously considered, whereas specific differences suggest a personalized aspect to such therapeutics with the possibility of a differential response.